SkinHealth Systems Inc. (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
0.6494
-0.0161 (-2.42%)
Jun 3, 2026, 1:53 PM EDT - Market open
SkinHealth Systems Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6.05 | -9.52 | -29.1 | -100.12 | 44.22 | -378.76 |
Depreciation & Amortization | 24.52 | 25.35 | 33.68 | 34.68 | 22.87 | 17.93 |
Stock-Based Compensation | 13.43 | 14.82 | 26.7 | 22.54 | 28.5 | 12.42 |
Other Adjustments | 7.78 | -3.54 | 12.25 | 41.29 | -56.93 | 336.2 |
Change in Receivables | 3.66 | 5.16 | 20.8 | 16.52 | -32.03 | -31.01 |
Changes in Inventories | 11.9 | 15.79 | -10.5 | -22.62 | -84.36 | -7.29 |
Changes in Accounts Payable | -11.01 | -7.18 | -43.78 | 44 | -2.95 | 10.52 |
Changes in Accrued Expenses | - | - | - | - | - | 24.78 |
Changes in Income Taxes Payable | - | - | - | - | - | -0.56 |
Changes in Other Operating Activities | -6.24 | -3.4 | 6.08 | -14.55 | -25.93 | -12.59 |
Operating Cash Flow | 28.94 | 37.49 | 16.13 | 21.75 | -106.6 | -28.36 |
Operating Cash Flow Growth | -19.59% | 132.34% | -25.82% | - | - | - |
Capital Expenditures | -0.48 | -0.3 | -0.76 | -3.83 | -10.85 | -11.2 |
Purchases of Intangible Assets | -5.19 | -4.86 | -6.04 | -9.22 | -6.55 | -4.42 |
Payments for Business Acquisitions | - | - | - | - | - | -22.9 |
Other Investing Activities | - | - | - | -18.46 | -1.48 | 0.78 |
Investing Cash Flow | -5.67 | -5.16 | -6.79 | -31.51 | -18.87 | -37.73 |
Short-Term Debt Issued | - | - | - | - | - | 5 |
Short-Term Debt Repaid | - | - | - | - | - | -5 |
Long-Term Debt Issued | 118.45 | 237.6 | - | - | - | 750 |
Long-Term Debt Repaid | -234.83 | -410.96 | -156.08 | - | - | -225.49 |
Net Long-Term Debt Issued (Repaid) | -116.38 | -173.35 | -156.08 | - | - | 524.51 |
Issuance of Common Stock | - | - | - | - | - | 188.38 |
Repurchase of Common Stock | -2.07 | -1.57 | -1.96 | -35.63 | -200.93 | - |
Net Common Stock Issued (Repurchased) | -2.07 | -1.57 | -1.96 | -35.63 | -200.93 | 188.38 |
Other Financing Activities | - | - | -0.3 | -1.82 | -4.32 | 246.14 |
Financing Cash Flow | -195.58 | -174.93 | -158.34 | -37.45 | -205.24 | 959.04 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 3.64 | 5.21 | -3.96 | 2.03 | -2.98 | -0.54 |
Net Cash Flow | -172.31 | -142.6 | -149 | -47.21 | -330.71 | 892.94 |
Free Cash Flow | 28.45 | 37.18 | 15.38 | 17.93 | -117.45 | -39.56 |
Free Cash Flow Growth | -23.48% | 141.79% | -14.21% | - | - | - |
FCF Margin | 9.61% | 12.36% | 4.60% | 4.50% | -32.10% | -15.21% |
Free Cash Flow Per Share | 0.22 | 0.27 | 0.11 | 0.14 | -0.79 | -0.39 |
Levered Free Cash Flow | -103.74 | -152.62 | -200.45 | -62.43 | -56.99 | 167.35 |
Unlevered Free Cash Flow | 0.63 | -3.09 | -82.01 | -90.95 | -126.42 | -18.13 |